Mylan sued by Schering over Simvastatin

In a Hatch-Waxman action, Mylan has been sued by Schering Corporation and MSP Singapore Company in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) [with a paragraph IV certification] with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg.